These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 17882719)

  • 21. Higher infused lymphocyte dose predicts higher lymphocyte recovery, which in turn, predicts superior overall survival following autologous hematopoietic stem cell transplantation for multiple myeloma.
    Hiwase DK; Hiwase S; Bailey M; Bollard G; Schwarer AP
    Biol Blood Marrow Transplant; 2008 Jan; 14(1):116-24. PubMed ID: 18158968
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peripheral blood progenitor cell mobilization with intermediate-dose cyclophosphamide, sequential granulocyte-macrophage-colony-stimulating factor and granulocyte-colony-stimulating factor, and scheduled commencement of leukapheresis in 225 patients undergoing autologous transplantation.
    Bashey A; Donohue M; Liu L; Medina B; Corringham S; Ihasz A; Carrier E; Castro JE; Holman PR; Xu R; Law P; Ball ED; Lane TA
    Transfusion; 2007 Nov; 47(11):2153-60. PubMed ID: 17958545
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DCEP chemotherapy followed by a single, fixed dose of pegylated filgrastim allows adequate stem cell mobilization in multiple myeloma patients.
    Zappasodi P; Nosari AM; Astori C; Ciapanna D; Bonfichi M; Varettoni M; Mangiacavalli S; Morra E; Lazzarino M; Corso A
    Transfusion; 2008 May; 48(5):857-60. PubMed ID: 18248573
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical impact and resource utilization after stem cell mobilization failure in patients with multiple myeloma and lymphoma.
    Gertz MA; Wolf RC; Micallef IN; Gastineau DA
    Bone Marrow Transplant; 2010 Sep; 45(9):1396-403. PubMed ID: 20062089
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of growth factor on the phenotype of subpopulations and on the kinetics of CD34+ cells in the peripheral blood and in grafts of peripheral stem cells in patients with non-Hodgkin's lymphoma indicated for autologous peripheral blood stem cell transplantation].
    Klabusay M; Lysák D; Hrabcáková V; Navrátil M; Coupek P; Mayer J
    Cas Lek Cesk; 2008; 147(6):319-24. PubMed ID: 18724529
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ideal body weight correlates better with engraftment after PBSC autograft than actual body weight, but is under-estimated in myeloma patients possibly due to disease-related height loss.
    Maclean PS; Parker AN; McQuaker IG; Clark AD; Farrell E; Douglas KW
    Bone Marrow Transplant; 2007 Oct; 40(7):665-9. PubMed ID: 17646841
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Complete remission status before autologous stem cell transplantation is an important prognostic factor in patients with multiple myeloma undergoing upfront single autologous transplantation.
    Kim JS; Kim K; Cheong JW; Min YH; Suh C; Kim H; Jo DY; Ryoo HM; Yoon SS; Lee JH;
    Biol Blood Marrow Transplant; 2009 Apr; 15(4):463-70. PubMed ID: 19285634
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase I trial of parathyroid hormone to facilitate stem cell mobilization.
    Ballen KK; Shpall EJ; Avigan D; Yeap BY; Fisher DC; McDermott K; Dey BR; Attar E; McAfee S; Konopleva M; Antin JH; Spitzer TR
    Biol Blood Marrow Transplant; 2007 Jul; 13(7):838-43. PubMed ID: 17580262
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prediction of mobilisation failure in patients with non-Hodgkin's lymphoma.
    Kuittinen T; Nousiainen T; Halonen P; Mahlamäki E; Jantunen E
    Bone Marrow Transplant; 2004 May; 33(9):907-12. PubMed ID: 15034543
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Number of megakaryocytic progenitors and adhesion molecule expression of stem cells predict platelet engraftment after allogeneic hematopoietic stem cell transplantation.
    Woo KS; Goh RY; Kim SH; Kwon HC; Kim HJ; Lee YH; Han JY
    Cytotherapy; 2007; 9(6):555-61. PubMed ID: 17882720
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peripheral blood progenitor cell collection without close monitoring of peripheral blood CD34+ cells: A feasible strategy for multiple myeloma or pre-treated Non-Hodgkin's Lymphoma patients mobilized with low-dose cyclophosphamide plus G-CSF.
    Callera F; Cavenaghi L; de Melo CM
    Transfus Apher Sci; 2009 Apr; 40(2):91-5. PubMed ID: 19233728
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mobilization of peripheral blood stem cells in myeloma with either pegfilgrastim or filgrastim following chemotherapy.
    Tricot G; Barlogie B; Zangari M; van Rhee F; Hoering A; Szymonifka J; Cottler-Fox M
    Haematologica; 2008 Nov; 93(11):1739-42. PubMed ID: 18728024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of thalidomide on stem cell collection and engraftment in patients with multiple myeloma.
    Ghobrial IM; Dispenzieri A; Bundy KL; Gastineau DA; Rajkumar SV; Therneau TM; Lacy MQ; Witzig TE; Litzow MR; Christensen BR; Hayman S; Pribula CG; Gertz MA
    Bone Marrow Transplant; 2003 Sep; 32(6):587-92. PubMed ID: 12953131
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management strategies for poor peripheral blood stem cell mobilization.
    Moog R
    Transfus Apher Sci; 2008 Jun; 38(3):229-36. PubMed ID: 18485822
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A feasible shortcut for the mobilization outcome: Steady state CD34 positive hematopoietic stem cells.
    Yüksel MK; Tekgündüz E; Sönmez C; Topcuoglu P; Yurtcu A; Demiriz I; Tetik A; Kayıkçı O; Cınarsoy M; Altuntaş F
    Transfus Apher Sci; 2012 Aug; 47(1):67-75. PubMed ID: 22658279
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mobilization of peripheral blood stem cells for autologous transplantation patients with hematological malignancies: Influence of disease, mobilization method, age and sex.
    Zhang C; Chen X; Zhang X; Gao L; Kong P; Wang Q; Peng X; Liu H
    Transfus Apher Sci; 2008 Aug; 39(1):21-8. PubMed ID: 18599353
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized comparison of peripheral blood hematopoietic progenitor cell level of 5/mm3 versus 50/mm3 as a surrogate marker to initiate efficient autologous blood stem cell collection.
    Kim MK; Kim S; Jang G; Lee SS; Sym SJ; Lee DH; Kim SW; Jang S; Park CJ; Chi HS; Huh J; Suh C
    J Clin Apher; 2007; 22(5):277-82. PubMed ID: 17880017
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation of residual leukocyte subsets with neutropenic fever during severe leukopenia after high-dose chemotherapy and autologous stem cell transplantation.
    Schnabel B; Schmidmaier R; Franke D; Emmerich B; Straka C
    Cytotherapy; 2006; 8(5):473-9. PubMed ID: 17050252
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors affecting hematopoietic progenitor cell mobilization: an analysis of 307 patients.
    Mendrone A; Arrais CA; Saboya R; Chamone Dde A; Dulley FL
    Transfus Apher Sci; 2008 Dec; 39(3):187-92. PubMed ID: 19036640
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transfusion-associated iron overload as a predictive factor for poor stem cell mobilization in patients with haematological malignancies.
    Park IH; Kim Y; Kim JS; Cheong JW; Song JW; Min YH
    Transfus Med; 2008 Apr; 18(2):97-103. PubMed ID: 18399843
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.